ODAIA news and milestones

Company

The provider's partnership with AI innovator Odaia offers deeper, broader insights to HCP activity.

Why therapies still take years to reach the patients who need them

Pharma's commercial model struggles to support precision medicine, slowing patient identification and delaying access to targeted therapies.

/PRNewswire/ -- JP Morgan Healthcare Conference - ODAIA and Pulse Health today announced a technology partnership that combines ODAIA

The life sciences sector is bracing for a year when AI delivers real returns, regulators move faster, and trial operations are finally built for modern science.

MM+M demoed tools from Lirio, Invoca, Odaia.ai, Publicis Health and Axonal.AI.

We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Philip Poulidis, CEO at Toronto-based ODAIA. Poulidis is…

2026 is set to be a banner year for M&A in biopharma, as buyers facing major patent cliffs fight for a small pool of late-stage assets.

Omnichannel didn't fail pharma. Our metrics did. In 2026, fixing that won't be optional.

/PRNewswire/ -- ODAIA today announced it is expanding its leadership to meet growing customer demand and accelerate market adoption. The company is adding life...

For decades, pharma sales strategies have been built on static lists and old data. Now, AI-driven models are replacing guesswork with live insights

How AI can help foster marketing-sales collaboration.

Health-tech companies have the potential to bridge gaps in Canadian health care by supporting and empowering government infrastructure

From research and health care practice to education, the Leslie Dan Faculty of Pharmacy is embedding AI as pillar of academic plan